SFI
Susquehanna Fundamental Investments’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-514,379
| Closed | -$4.55M | – | 862 |
|
|
2023
Q1 | $4.55M | Sell |
514,379
-138,395
| -21% | -$1.22M | 0.11% | 237 |
|
|
2022
Q4 | $5.95M | Buy |
652,774
+203,000
| +45% | +$1.85M | 0.1% | 254 |
|
|
2022
Q3 | $3.63M | Buy |
+449,774
| New | +$3.63M | 0.06% | 404 |
|
|
2022
Q1 | $3.19M | Sell |
340,153
-256,272
| -43% | -$2.41M | 0.06% | 422 |
|
|
2021
Q4 | $4.78M | Buy |
596,425
+392,466
| +192% | +$3.14M | 0.13% | 206 |
|
|
2021
Q3 | $1.99M | Sell |
203,959
-167,724
| -45% | -$1.63M | 0.04% | 602 |
|
|
2021
Q2 | $3.68M | Sell |
371,683
-255,737
| -41% | -$2.53M | 0.07% | 396 |
|
|
2021
Q1 | $7.24M | Sell |
627,420
-512,923
| -45% | -$5.92M | 0.12% | 223 |
|
|
2020
Q4 | $11M | Buy |
1,140,343
+596,332
| +110% | +$5.75M | 0.2% | 131 |
|
|
2020
Q3 | $4.9M | Buy |
544,011
+203,811
| +60% | +$1.84M | 0.15% | 196 |
|
|
2020
Q2 | $4.2M | Buy |
+340,200
| New | +$4.2M | 0.2% | 128 |
|
|
2019
Q1 | – | Sell |
-265,845
| Closed | -$4.1M | – | 431 |
|
|
2018
Q4 | $4.1M | Sell |
265,845
-103,400
| -28% | -$1.59M | 0.72% | 37 |
|
|
2018
Q3 | $7.95M | Sell |
369,245
-60,500
| -14% | -$1.3M | 1.35% | 10 |
|
|
2018
Q2 | $10.5M | Buy |
429,745
+73,300
| +21% | +$1.78M | 1.55% | 3 |
|
|
2018
Q1 | $6.09M | Buy |
+356,445
| New | +$6.09M | 0.72% | 19 |
|